Diagnamed Holdings Corp, a Canadian public company listed on the Canadian National Stock Exchange, specializes in developing and providing diagnostic imaging solutions for various medical applications. The company’s mission is to revolutionize the medical imaging industry by offering high-quality, cost-effective, and user-friendly solutions to medical professionals globally.

As of January 5, 2026, Diagnamed Holdings Corp’s share price closed at CAD 0.07. This price is within the 52-week range of CAD 0.02 to CAD 0.14, reflecting significant volatility over the past year. The company’s market capitalization stands at CAD 7,641,128, indicating its current valuation in the market.

The company’s financial metrics reveal a challenging economic landscape. Diagnamed Holdings Corp has a price-to-earnings ratio of -4.96, underscoring the company’s current lack of profitability. Additionally, the price-to-book ratio is -81.7087, suggesting that the market value of the company is significantly lower than its book value, a reflection of sustained losses.

In recent developments, Diagnamed Holdings Corp, also trading as Diagnamed Inc. (OTC: DMDM), reported no new updates since its last disclosure on December 10, 2025. At that time, the company announced an acquisition agreement to acquire the Colchester East Natural Hydrogen Project in Nova Scotia. This strategic move indicates the company’s interest in diversifying its portfolio and exploring new ventures beyond its core diagnostic imaging solutions.

The stock’s recent trading activity shows a modest recovery towards the upper bound of its 52-week range. This trend suggests a gradual consolidation phase following a prolonged period of decline. The stock reached its peak of CAD 0.14 in early October 2025, before experiencing a significant drop to a low of CAD 0.02 in mid-May 2025.

Overall, Diagnamed Holdings Corp is navigating a complex financial environment, marked by volatility and negative valuation metrics. However, its strategic acquisition and focus on innovation in the medical imaging sector may provide avenues for future growth and stabilization.